红素作为神经保护剂在CKD相关认知功能障碍中的有效性:文学系统性审查
Michelangela Barbieri1, Paolo Chiodini2, Piergiacomo Di Gennaro2
1Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.
Pharmacological research
|March 17, 2024
概括
复合人体红色素 (rHuEPO) 可能改善慢性病 (CKD) 患者的认知功能. 这篇评论表明rHuEPO提供神经保护,可能有利于功能受损的个体的大脑健康.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性病 (CKD) 与认知障碍有关.
- 在临床前模型中,红素 (EPO) 和它的受体表现出神经保护性质.
- 复合人体EPO (rHuEPO) 用于治疗CKD患者的贫血.
研究的目的:
- 系统地审查关于rHuEPO在功能受损患者的认知益处的研究.
- 在CKD相关认知缺陷的背景下评估rHuEPO的神经保护潜力.
主要方法:
- 在Pubmed,Cochrane图书馆,Scopus和科学网络 (1990-2023) 的系统文献搜索.
- 分析了24项选定的研究,评估了设计,样本大小,参与者特征,干预和结果.
- 专注于神经心理测试和脑电图 (EEG) 测量.
主要成果:
- 在CKD患者中,rHuEPO治疗证明了大脑功能的增强.
- 观察到神经心理测试的表现有所改善.
- 研究人员注意到对脑电图测量的积极影响.
结论:
- rHuEPO显示出作为神经保护剂的承诺,用于管理CKD的认知障碍.
- 进一步的研究可能会巩固rHuEPO在CKD患者神经健康中的作用.
相关概念视频
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
123
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
123
Electroconvulsive Therapy
39
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
39
Erythropoiesis
4.2K
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
4.2K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
428
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
428


